Endo Pharmaceuticals to Hold Conference Call on Fourth Quarter and Full-Year 2007 Financial Results
           

CHADDS FORD, PA--(Marketwire - February 18, 2008) -  Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP), a market leader in pain management, will announce its financial
results for the fourth quarter and full-year ended December 31, 2007 before
the market opens on February 22, 2008, and will hold a conference call at
11:00 a.m. ET that day to discuss these results.

Nancy J. Wysenski, Chief Operating Officer, Charles A. Rowland, Jr., Chief
Financial Officer, and David A. Lee, M.D., Ph.D., Chief Scientific Officer,
will host the call.

           

http://www.marketwire.com/mw/release.do?id=822170&sourceType=3